Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

A dose- and time-controllable syngeneic animal model of breast cancer microcalcification.

Liu F, Misra P, Lunsford EP, Vannah JT, Liu Y, Lenkinski RE, Frangioni JV.

Breast Cancer Res Treat. 2010 Jul;122(1):87-94. doi: 10.1007/s10549-009-0535-6. Epub 2009 Sep 17.

2.

Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification.

Liu F, Bloch N, Bhushan KR, De Grand AM, Tanaka E, Solazzo S, Mertyna PM, Goldberg N, Frangioni JV, Lenkinski RE.

Mol Imaging. 2008 Jul-Aug;7(4):175-86.

3.

The short-term effects of repetitive E. coli-derived rhBMP-2 administration through intravenous injection in rats.

Lee JH, Lee EN, Nam SH.

Drug Chem Toxicol. 2014 Jan;37(1):40-7. doi: 10.3109/01480545.2013.806530. Epub 2013 Jul 10.

PMID:
23841455
4.

Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy.

Dou S, Smith M, Wang Y, Rusckowski M, Liu G.

Cancer Biother Radiopharm. 2013 May;28(4):335-42. doi: 10.1089/cbr.2012.1351. Epub 2013 Mar 7.

5.

Near-infrared fluorescence imaging of microcalcification in an animal model of breast cancer.

Lenkinski RE, Ahmed M, Zaheer A, Frangioni JV, Goldberg SN.

Acad Radiol. 2003 Oct;10(10):1159-64.

PMID:
14587634
6.

Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors.

Head HW, Dodd GD 3rd, Bao A, Soundararajan A, Garcia-Rojas X, Prihoda TJ, McManus LM, Goins BA, Santoyo CA, Phillips WT.

Radiology. 2010 May;255(2):405-14. doi: 10.1148/radiol.10090714.

7.

Use of avidin/biotin-liposome system for enhanced peritoneal drug delivery in an ovarian cancer model.

Zavaleta CL, Phillips WT, Soundararajan A, Goins BA.

Int J Pharm. 2007 Jun 7;337(1-2):316-28. Epub 2007 Jan 14.

PMID:
17276633
8.

Healing of large segmental bone defects induced by expedited bone morphogenetic protein-2 gene-activated, syngeneic muscle grafts.

Betz OB, Betz VM, Abdulazim A, Penzkofer R, Schmitt B, Schröder C, Augat P, Jansson V, Müller PE.

Hum Gene Ther. 2009 Dec;20(12):1589-96. doi: 10.1089/hum.2009.037.

PMID:
19572783
9.

High-resolution computed tomography of single breast cancer microcalcifications in vivo.

Inoue K, Liu F, Hoppin J, Lunsford EP, Lackas C, Hesterman J, Lenkinski RE, Fujii H, Frangioni JV.

Mol Imaging. 2011 Aug;10(4):295-304. doi: 10.2310/7290.2010.00050. Epub 2011 Apr 1.

10.

SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.

Müller C, Forrer F, Schibli R, Krenning EP, de Jong M.

J Nucl Med. 2008 Feb;49(2):310-7. doi: 10.2967/jnumed.107.045856. Epub 2008 Jan 16.

11.

Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.

Li F, Cheng T, Dong Q, Wei R, Zhang Z, Luo D, Ma X, Wang S, Gao Q, Ma D, Zhu X, Xi L.

Nucl Med Biol. 2015 Mar;42(3):256-62. doi: 10.1016/j.nucmedbio.2014.11.001. Epub 2014 Nov 13.

PMID:
25516099
12.

Importance of progesterone in DNA synthesis of pregnancy-dependent mammary tumors in mice.

Yanai R, Nagasawa H.

Int J Cancer. 1976 Sep 15;18(3):317-21.

PMID:
986372
13.

Imaging, biodistribution and therapy potential of halogenated tamoxifen analogues.

Yang DJ, Li C, Kuang LR, Price JE, Buzdar AU, Tansey W, Cherif A, Gretzer M, Kim EE, Wallace S.

Life Sci. 1994;55(1):53-67.

PMID:
8015349
14.

Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.

Mekkaoui C, Jadbabaie F, Dione DP, Meoli DF, Purushothaman K, Belardinelli L, Sinusas AJ.

JACC Cardiovasc Imaging. 2009 Oct;2(10):1198-208. doi: 10.1016/j.jcmg.2009.06.013.

15.

Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent.

Choi SR, Yang B, Plössl K, Chumpradit S, Wey SP, Acton PD, Wheeler K, Mach RH, Kung HF.

Nucl Med Biol. 2001 Aug;28(6):657-66.

PMID:
11518647
16.

Tumor imaging using a standardized radiolabeled adapter protein docked to vascular endothelial growth factor.

Blankenberg FG, Mandl S, Cao YA, O'Connell-Rodwell C, Contag C, Mari C, Gaynutdinov TI, Vanderheyden JL, Backer MV, Backer JM.

J Nucl Med. 2004 Aug;45(8):1373-80.

17.

Radioiodinated prolactin as a potential mammary tumor localizing agent.

Shani J, Scott JZ, Young D, Wolf W.

Int J Nucl Med Biol. 1984;11(2):149-52.

PMID:
6480256
18.
19.

The reaction of bone to tumor growth from human breast cancer cells in a rat spine single metastasis model.

Liang H, Ma SY, Mohammad K, Guise TA, Balian G, Shen FH.

Spine (Phila Pa 1976). 2011 Apr 1;36(7):497-504. doi: 10.1097/BRS.0b013e3181d8906f.

20.

Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.

Erba PA, Manfredi C, Lazzeri E, Minichilli F, Pauwels EK, Sbrana A, Strauss HW, Mariani G.

J Nucl Med. 2010 May;51(5):775-81. doi: 10.2967/jnumed.109.071621. Epub 2010 Apr 15.

Supplemental Content

Support Center